March 14, 2024 Improving surgical feasibility in rectal cancer care David W. Larson, M.D., M.B.A., Chris L. Hallemeier, M.D., Jin, M.D., part of the colorectal cancer care team at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, highlight Mayo Clinic’s expertise in advanced surgical techniques and a comprehensive range of treatment options for rectal cancer, optimizing the chances of a cure. Jan. 23, 2024 Pediatric Brain Tumor Program at Mayo Clinic David Daniels, M.D. and Jonathan D. Schwartz, D.O., M.P.H. share about the technology, the comprehensive team and advantages of referring a pediatric patient diagnosed with a brain tumor to Mayo Clinic. Jan. 23, 2024 Neurosurgical interventions for chronic pain Rushna P. Ali, M.D., a neurosurgeon at Mayo Clinic in Rochester, Minnesota, leads a webinar discussion about the neurosurgical interventions available for patients with chronic pain. Oct. 24, 2023 CAR-T Cell Therapy: Current Uses and Future Possibilities Chimeric antigen receptor (CAR)-T cell therapy is a promising new immunotherapy for certain cancers of the blood, providing long-lasting responses for some patients. April 14, 2023 Surgical treatments for melanoma All patients with melanoma receive surgery as part of their treatment plans, and they may need other therapies as well. Care plans can include preoperative systemic or lesion-directed treatment and advanced procedures such as sentinel lymph node surgery. March 24, 2023 Advancements in gastric cancer treatment offer patients hope for long-term survival Mayo Clinic gastric surgeons are successfully performing minimally invasive and complex multivisceral surgeries for patients who traditionally have not been candidates for surgery. They explain that accurate staging of gastric tumors is crucial to providing the right treatment. March 24, 2023 Hepatic artery infusion pump chemotherapy: Surgical treatment for colorectal liver metastases For patients with previously unresectable colorectal liver metastases, hepatic artery infusion pump chemotherapy can provide surgical options. Cornelius A. Thiels, D.O., M.B.A., explains how the pump works for select patients. Feb. 06, 2023 Optimizing outcomes for patients with nonmetastatic pancreatic cancer Mark J. Truty, M.D., and colleagues discuss new research improving outcomes in pancreatic cancer. The team shares updates on staging exams, optimal response assessment and novel surgical procedures for traditionally inoperable patients. Dec. 07, 2022 GI Neoplasia Clinic There are many new and established ways to test and treat patients with gastrointestinal neoplasia at Mayo Clinic. Aug. 09, 2022 Kidney cancer innovations and collaborations Mayo Clinic kidney cancer experts discuss the multispecialty integrated approach they take to kidney cancer care. At Mayo Clinic Comprehensive Cancer Center, renal cancer experts draw on the best surgical, imaging, technical and pathology practices supported by care providers with specific kidney cancer expertise. Aug. 09, 2022 Testicular cancer advancements and innovations Mayo Clinic testicular cancer experts explain the methods they are using to work toward their goal of 100% cure for patients with testicular cancer. Advanced diagnosis and screening practices, collaboration in multidisciplinary teams, excellent therapy options and clinical trials help Mayo Clinic Comprehensive Cancer Center lead in innovation. Aug. 09, 2022 Bladder cancer discoveries implemented in multidisciplinary teams Bladder cancer experts at Mayo Clinic Comprehensive Cancer Center work in multidisciplinary teams to stay at the forefront of medical research and discoveries. Innovations in diagnostics, drug development, genomics, immunotherapy, surgery and imaging allow Mayo Clinic physicians the best options in treating bladder cancer. Aug. 09, 2022 Prostate cancer innovations move the field forward Prostate cancer experts at Mayo Clinic Comprehensive Cancer Center work in an integrated genitourinary practice, which allows them the size and scope they need to drive this rapidly moving field forward. Aug. 09, 2022 Quality liver cancer screening provides the most favorable treatment options Sumera I. Ilyas, M.B.B.S., a gastroenterologist at Mayo Clinic Comprehensive Cancer Center, explains that potentially curative liver cancer treatments are available only for early-stage disease. Quality liver cancer screening and knowledge of when screening and further testing should occur are imperative. Aug. 09, 2022 Liver cancer innovations and advanced treatment options Liver cancer specialists at Mayo Clinic Comprehensive Cancer Center offer hope to patients in the form of the highest quality therapies available. At the Cancer Center, patients with liver cancer may have access to personalized chemotherapy regimens, proton beam and other highly focused radiation therapies and prostate-specific membrane antigen. Aug. 08, 2022 Managing indolent lymphoma collaboratively Mayo Clinic hematologist and oncologist Jose (J.C.) C. Villasboas Bisneto, M.D., discusses follicular lymphoma and other indolent B-cell non-Hodgkin lymphomas. He aims to collaborate with his patients' home care teams to manage this slow growing disease. Aug. 08, 2022 Large B-cell lymphoma: Innovative treatment and care plans Grzegorz S. Nowakowski, M.D., hematologist and oncologist at Mayo Clinic Comprehensive Cancer Center, explains the rapid advancements made in the treatment of large B-cell lymphoma. With unprecedented access to novel agents, lymphoma clinicians are now developing treatment plans such as CAR-T cell therapy and drug antibody conjugates. July 13, 2022 Left cranial fiducial marker placement Watch Timothy W. Olsen, M.D., an ophthalmologist and vitreoretinal surgeon at Mayo Clinic in Rochester, Minnesota, demarcate a large choroidal melanoma using ceramic fiducial marker. Dec. 15, 2021 Fertility preservation in women and girls Zaraq Khan, M.B.B.S., discusses fertility preservation options presented in a paper he and colleagues published in the April 2020 issue of Mayo Clinic Proceedings. Dec. 07, 2021 Innovative melanoma therapies grounded in collaborative research and practice at Mayo Clinic Mayo Clinic's melanoma program uses the latest science and care practices. Physician-scientists collaborate on patient care, innovative research and diagnostic excellence to provide highly individualized melanoma care. Aug. 28, 2021 Cholangiocarcinoma discoveries and treatment approaches Rory L. Smoot, M.D., Mayo Clinic surgical oncologist, discusses the discoveries made in the treatment of cholangiocarcinoma and other biliary tract cancers. Aug. 27, 2021 Trends and treatment options in colorectal liver metastases Mayo Clinic surgical oncologist Sean P. Cleary, M.D., discusses the safe and aggressive treatment options available when colorectal cancer has metastasized to the liver. Aug. 19, 2021 Advances for multiple myeloma treatments Mayo Clinic hematologists S. Vincent Rajkumar, M.D., and Yi Lin, M.D., Ph.D., discuss the immunotherapies available for treatment of multiple myeloma. For myeloma, Mayo Clinic specialists believe immunotherapy is the way of the future. June 30, 2021 Advances in new applications of immunotherapy for glioblastoma Mayo Clinic is creating the future of brain tumor care by advancing the application of immunotherapy for glioblastoma. June 30, 2021 Pioneering glioblastoma care and treatments Mayo Clinic provides advanced glioblastoma care to help your patients with serious, complex or rare brain tumors. June 08, 2021 Head and neck 3D printing for reconstruction Mayo Clinic specialists share their approach to head and neck cancer treatment and reconstruction using 3D printing. June 08, 2021 Head and neck cancer: De-escalation and transoral surgery Mayo Clinic head and neck cancer specialists discuss de-escalation and transoral surgery treatment advances and the benefits to patients. May 25, 2021 Cutting edge approaches to lymphoma care (en espanol) Mayo Clinic specialists share the latest in lymphoma treatment including chimeric antigen receptor (CAR)-T cell therapy. May 25, 2021 Innovative treatments and risk adaptive therapies for myeloma Mayo Clinic myeloma specialists discuss the latest in treatment and risk adaptive therapies. March 17, 2021 Exploring colorectal cancer clinical trials Mayo Clinic colorectal cancer experts Jeremy C. Jones, M.D., and Tanios S. Bekaii-Saab, M.D., provide an overview of colorectal cancer clinical trials that are transforming the way this disease is treated. Jan. 12, 2021 What is a pelvic exenteration? Amanika Kumar, M.D., a gynecological oncologist at Mayo Clinic in Rochester, Minnesota, explains the indications and goals of pelvic exenteration surgery: anterior exenteration, posterior exenteration and total exenteration. Jan. 05, 2021 Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy Mayo Clinic gastroenterologist Michael J. Levy, M.D., discusses endoscopic ultrasound-guided pancreatic anti-tumoral therapy for the treatment of pancreatic masses. Jan. 04, 2021 Glioblastoma brain and spinal cord tumor care at Mayo Clinic Mayo Clinic neuro-oncologist Wendy J. Sherman, M.D., discusses glioblastoma, a malignant brain and spinal cord tumor. Sept. 18, 2020 Proton beam treatment at Mayo Clinic Mayo Clinic's Proton Beam Therapy Program uses the latest form of proton beam therapy: pencil beam scanning. This advance allows Mayo radiation oncologists to deliver higher doses of radiation to cancer cells while sparing healthy tissue. Sept. 04, 2020 Why refer to Mayo Clinic for proton beam therapy Learn about Mayo Clinic's approach to proton beam therapy treatment and how Mayo radiation oncologists collaborate with referring providers to provide the best care possible for your patients. Sept. 03, 2020 Use of radiotherapies in breast cancer Learn about radiotherapies in breast cancer. Aug. 27, 2020 Strategies for effective breast cancer treatment Learn about the latest strategies for effective breast cancer treatment. Aug. 13, 2020 Innovations in surgical protocols for breast cancer Learn about innovations in surgical protocols for breast cancer. Aug. 10, 2020 Left choroidal melanoma Watch Lauren A. Dalvin, M.D., an ophthalmologist with subspecialty training in ocular oncology at Mayo Clinic in Rochester, Minnesota, treat a choroidal melanoma using plaque therapy. July 30, 2020 Exploring clinical trials for breast cancer Learn about the latest clinical trials for breast cancer. July 03, 2020 Signs of high risk breast cancer Learn about the latest innovations for high risk breast cancer. June 22, 2020 Cutting-edge treatment and research for brain tumors Mayo Clinic neurologists and neurosurgeons discuss the most advanced treatments and the future of brain tumor therapy. March 02, 2020 Symptoms and treatment of pancreatic neuroendocrine tumors How to spot the symptoms of pancreatic neuroendocrine tumors so your patients can receive the right treatment. Jan. 27, 2020 Treatment innovations for pancreatic adenocarcinoma Learn about the latest treatment innovations for pancreatic adenocarcinoma and how these innovations have extended survival. Dec. 05, 2019 Minimally invasive surgery, sentinel lymph node biopsy produce excellent perioperative outcomes for patients with endometrial cancer Andrea Mariani, M.D., M.S., a gynecological surgeon at Mayo Clinic in Rochester, Minnesota, discusses the importance of minimally invasive surgery and sentinel nodes in the evolution of surgical treatment of endometrial cancer. Nov. 05, 2019 Robotic bronchoscopy Robotic bronchoscopy uses flexible robotics that enable new possibilities in endoscopy. Karen L. Swanson, D.O., pulmonologist at Mayo Clinic in Arizona, shares the latest on robotic bronchoscopy and looks ahead to what this means for lung cancer. Oct. 31, 2019 HPV-related oropharynx cancer discoveries Experts from Mayo Clinic's Head and Neck Cancer Center discuss the latest discoveries in HPV-related oropharynx cancers and the importance of spotting symptoms to ensure your patient receives the tests needed to diagnose and treat the cancer. Oct. 14, 2019 Newly discovered autoimmune disease associated with testicular cancer Sean J. Pittock, M.D., an autoimmune neurologist at Mayo Clinic, discusses a newly discovered autoimmune disease that appears to affect men with testicular cancer. Sept. 05, 2019 Multifocal lung cancer discussion and case presentation Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on VATS left lower lobectomy in the setting of multiple lung lesions. Sept. 05, 2019 Minimally invasive approach to Pancoast tumor using 3D printing Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on hybrid Pancoast tumor resection. Sept. 05, 2019 How to do 3D modeling for cardiothoracic surgery Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares how to use 3D modeling for CT surgery. Aug. 28, 2019 Gastric cancer overview Travis E. Grotz, M.D. discusses stomach (gastric) cancer risks, signs and symptoms, diagnosis, staging, and treatments including hyperthermic intraperitoneal chemotherapy (HIPEC) and immunotherapy. July 26, 2018 Clinical trial regarding endometrial cancer and stress urinary incontinence Gynecologic oncologist Gretchen E. Glaser, M.D., with Mayo Clinic in Rochester, Minnesota, discusses a study that compares the quality of life and clinical outcomes among women with endometrial cancer and stress urinary incontinence who have concurrent surgery with that of women who do not have concurrent surgery. July 26, 2018 Recurrent ovarian cancer: Treatment and clinical trials There are many options available to treat recurrent ovarian cancer, even if it has recurred more than once. Recurrence is common in patients with ovarian cancer. July 26, 2018 Obesity and endometrial cancer Women who are obese are six times more likely to develop endometrial cancer than women who maintain a healthy weight. Amanika Kumar, M.D., discusses the relationship between obesity and endometrial cancer and treatment to ensure long-term, sustainable weight loss. March 17, 2017 Advances in colorectal cancer screening Mayo Clinic physicians John B. Kisiel, M.D., and David W. Larson, M.D., M.B.A., discuss the latest advancements in colorectal cancer screening, as well as the latest surgical techniques available for people with colorectal cancer. March 08, 2017 Demystifying sarcoma Medical oncologists, Scott H. Okuno, M.D., Steven I. Robinson, M.B.B.S., and orthopedic surgeon, Peter S. Rose, M.D., discuss sarcomas — a group of rare soft tissue and bone cancers — and the unique treatment options for these cancers. Feb. 28, 2017 A multidisciplinary approach to genitourinary cancers Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer. Jan. 19, 2017 Unlocking the power of gene expression: Molecular classification of brain tumors Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes. Jan. 09, 2017 Chromoendoscopy for inflammatory bowel disease Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease. June 10, 2016 Researchers identify best drug therapy for rare, aggressive pancreatic cancer Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care. March 01, 2016 Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer Radiation therapy improves survival times in patients who are candidates for pancreatic cancer surgery. Aug. 05, 2015 Methylated DNA markers and whole-body cancer screening John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors. June 09, 2015 Proton therapy has advantages over IMRT for advanced nasal cavity and paranasal sinus cancer Robert L. Foote, M.D., comments on findings of a new study by radiation oncologists at Mayo Clinic, comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base. Nov. 18, 2014 Treatment for people with cholangiocarcinoma at Mayo Clinic Rory L. Smoot, M.D., describes treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma. Oct. 31, 2014 Bladder cancer treatment options R. Jeffrey Karnes, M.D., consultant and associate professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into subcategories, and the treatments dramatically differ. Invasive treatments can include an ileal neobladder created from the patient's small intestine, which can provide the best quality of life. Oct. 08, 2014 Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors. Oct. 08, 2014 Precursor of multiple myeloma more common in blacks than whites, Mayo study finds Blacks may be twice as likely as whites to develop multiple myeloma because they are also more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance. Oct. 07, 2014 Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups. Oct. 06, 2014 Tissue testing during breast cancer lumpectomies prevents need for re-operation 96 percent of time Unique laboratory testing during breast cancer lumpectomies to make sure surgeons removed all the cancerous tissue spares patients the need for a repeat operation in roughly 96 percent of cases at Mayo Clinic in Rochester, Minnesota. Oct. 06, 2014 Chemo after radiation therapy improves brain cancer survival A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years. Oct. 01, 2014 Less-radical procedures offer similar cancer control compared with surgery for kidney cancer patients Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology. Aug. 11, 2014 Mesalamine dose may lower marker of bowel inflammation Edward V. Loftus Jr., M.D., discusses an article looking at the ability of a drug to drive down calprotectin, a marker of bowel inflammation, in people who have ulcerative colitis. July 08, 2014 Mayo Clinic researchers help to shine new light on bladder cancer tumors Mayo Clinic researchers help to shine new light on bladder cancer tumors. June 17, 2014 Grand Rounds: Less Invasive Axillary Surgery After Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071 Judy C. Boughey, M.D., presents Less Invasive Axillary Surgery after Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071. May 22, 2014 Choline C-11: Pulling back the curtain on prostate cancer Mayo Clinic has integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to prostate cancer patients. Feb. 21, 2014 Biopsy-based predictors of prostate cancer mortality: The Mayo Model Matthew K. Tollefson, M.D., provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting. Oct. 16, 2013 Stem cell transplantation as a treatment for multiple myeloma — Mayo Clinic Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones. Dec. 06, 2012 Aromatase inhibitors in breast cancer survivors Sandhya Pruthi, M.D., director of the Breast Diagnostic Clinic at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on managing aromatase inhibitors in breast cancer survivors. Nov. 19, 2012 Diagnosing and managing patients with BRCA mutations Sandhya Pruthi, M.D., consultant in the Breast Diagnostic Clinic at Mayo Clinic in Rochester, Minnesota, discusses her December 2010 Mayo Clinic Proceedings article on diagnostic and management approaches to patients with BRCA mutations that put them at higher risk of breast and ovarian cancers. Nov. 02, 2012 Malignant fibrous histiocytoma in CLL and Non-Hodgkin lymphoma Jerry D. Brewer, M.D., M.S., a dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the August 2011 issue of Mayo Clinic Proceedings. Oct. 18, 2012 Common musculoskeletal tumors of childhood and adolescence Carola A S. Arndt, M.D., a pediatric hematologist from Mayo Clinic in Rochester, Minnesota, discusses her article appearing in the May 2012 issue of Mayo Clinic Proceedings. Jan. 16, 2012 Mayo Pancreas Clinic among world's best Santhi Swaroop Vege, M.D., explains what distinguishes the Pancreas Clinic at Mayo Clinic's campus in Minnesota from other elite centers, including renowned specialists devoted exclusively to pancreatic disease. April 12, 2011 Study shows potential to prevent hospitalizations in brain tumor patients In a retrospective five-year study, researchers at Mayo Clinic found that common causes of hospitalization for patients with malignant brain tumors, such as seizures, are potentially preventable. March 29, 2010 Gene is linked to lung cancer development in never smokers A five-center collaborative study that scanned the genomes of thousands of "never smokers" diagnosed with lung cancer as well as healthy never smokers has found a gene they say could be responsible for a significant number of those cancers. June 02, 2009 DNA stool test for colon cancer — Mayo Clinic Doctors at Mayo Clinic have studied and improved upon a noninvasive screening test that requires no preparation or procedure. The test detects cancer or precancerous polyps by measuring DNA in your stool. Medical Professionals Cancer Videos